drug · antibody drug conjugate
patient view →disitamab vedotin
Phase 2updated 2mo agoby $PFE PFIZER INC🔗 ChEMBL
Phase 2community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Phase 3 (across all indications), with 12 investigational indications.
targets
Receptor tyrosine-protein kinase erbB-2Tubulin
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that